Molluscum contagiosum classification

Molluscum contagiosum Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Molluscum contagiosum from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
History and Symptoms
Physical Examination
Laboratory Findings
X ray
Ultrasound
CT Scan
MRI
Other Imaging Studies
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview

Restriction endonuclease analysis permits classification of MCV into

• The overview section should include the disease name in the first sentence.
• The goal is to summarize the page in several sentences, usually stating the categories that the disease is classified by.
• To see an example, click here.

Template

• Overview for Classification of Non-Malignant Diseases

• First Sentence:

Molluscum contagiosum may be classified according to restriction endonuclease analysis into at least two types; type 1 and type 2. Type 1 is more common.

OR

[Disease name] may be classified into [Large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

[Disease name] may be classified into acute and chronic forms, depending on the timing of presentation and duration.

• Examples:

Example 1: Silicosis may be classified according to the duration of exposure, development of symptoms, pulmonary function, and findings on chest imaging into 5 subtypes: simple chronic, interstitial pulmonary fibrosis, accelerated silicosis, and acute silicosis.

Example 2: Legionellosis may be classified according to the affected organ system and the clinical presentation into 3 subtypes: Legionnaires’ disease, Pontiac fever, and extrapulmonary infection.

Example 3: Diffuse large B cell lymphoma may be classified into 14 subtypes based on immunophenotyping/genetic testing.

Example 4: Diffuse large B cell lymphoma may be classified into several subtypes based on immunophenotyping and genetic testing.

Example 5: Mediastinitis may be classified into acute and chronic forms, depending on the timing of presentation and duration.

• Additional Sentences

Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

• Examples:

Other variants of cholecystitis include xanthogranulomatous cholecystitis, emphysematous cholecystitis, eosinophilic and lymphoeosinophilic cholecystitis.

• Overview for Staging of Malignant Diseases

• First Sentence:

According to the [Staging system], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].

OR

[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].

OR

The staging of [malignancy] is based on the [staging system].

OR

There is no established system for the staging of [malignancy name].

, but there is as yet no consistent evidence relating the virus type to the clinical appearance of the lesions or to their anatomical distribution.